Clinical Trials Directory

Trials / Completed

CompletedNCT04943393

Remote Neurocognitive and Psychological Assessment in PKU

Remote Assessment of Working Memory and Anxiety in Individuals With Early-Treated Phenylketonuria (PKU)

Status
Completed
Phase
Study type
Observational
Enrollment
84 (actual)
Sponsor
University of Missouri-Columbia · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

PKU is a rare autosomal recessive condition associated with disruption in dopamine synthesis. Although early diagnosis and treatment prevent the severe impairments associated with untreated PKU, individuals with early-treated PKU (ETPKU) nonetheless experience significant sequelae, including impaired working memory and increased risk for anxiety problems. Past research with other clinical populations (e.g., generalized anxiety disorder) suggests that the two phenomena may be linked, with increased anxiety contributing to poorer WM performance. Currently we propose to initiate an exciting new line of research examining the potential relationship between anxiety and WM in ETPKU. The proposed study will also apply remote neuropsychological performance-based assessment to the study of ETPKU and thus overcoming the geographical limitations/challenges associated with recruitment of participants with this rare disease.

Conditions

Interventions

TypeNameDescription
OTHERnointerventionNointervention

Timeline

Start date
2020-11-24
Primary completion
2021-10-02
Completion
2021-10-02
First posted
2021-06-29
Last updated
2022-04-22

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04943393. Inclusion in this directory is not an endorsement.